DeepMed Research

University Of Leeds

🇸🇪Sweden

Country: 🇸🇪Sweden

Ownership: Private

Established: 1904-01-01

Employees: 5K

Market Cap: -

Website: http://www.leeds.ac.uk

Clinical Trials

Investigating Variation in Hospital Acute Coronary Syndrome Outcomes

Completed

Conditions: Acute Myocardial Infarction

First Posted Date: 2013-03-08

Last Posted Date: 2013-03-08

Lead Sponsor: University of Leeds

Target Recruit Count: 5555

Registration Number: NCT01808027

Locations: 🇬🇧
University of Leeds, Leeds, West Yorkshire, United Kingdom

Pilot Trial of "My Meal Mate" (MMM), a Smartphone Application for Weight Loss

Phase 2

Completed

Conditions: Obesity
Overweight

Interventions: Behavioral: Paper food diary
Behavioral: Online food diary
Behavioral: "My Meal Mate" (smartphone application)

First Posted Date: 2012-12-06

Last Posted Date: 2012-12-07

Lead Sponsor: University of Leeds

Target Recruit Count: 128

Registration Number: NCT01744535

Locations: 🇬🇧
University of Leeds, Leeds, West Yorkshire, United Kingdom

Vorinostat, Bortezomib and Dexamethasone in Multiple Myeloma (MUKFour)

Phase 2

Completed

Conditions: Multiple Myeloma

Interventions: Drug: Vorinostat Velcade Dexamethasone

First Posted Date: 2012-11-02

Last Posted Date: 2021-08-16

Lead Sponsor: University of Leeds

Target Recruit Count: 16

Registration Number: NCT01720875

Locations: 🇬🇧
Nottingham University Hospital, Nottingham, Nottinghamshire, United Kingdom
🇬🇧
University Hospital Southampton, Southampton, United Kingdom

Developing and Evaluating the Yorkshire Dialysis Decision Aid

Phase 1

Completed

Conditions: Chronic Kidney Failure

Interventions: Other: Decision Aid
Other: Decision Aid + values task
Other: Decision aid + patient stories

First Posted Date: 2012-08-23

Last Posted Date: 2014-05-01

Lead Sponsor: University of Leeds

Target Recruit Count: 488

Registration Number: NCT01671228

Locations: 🇬🇧
Bradford Teaching Hospital, Bradford, Yorkshire, United Kingdom
🇬🇧
Hull and East Yorkshire Hospital Trust, Hull, East Yorkshire, United Kingdom
🇬🇧
Sheffield Northern General Teaching Hospital, Sheffield, South Yorkshire, United Kingdom

and more 3 locations

Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease-2

Not Applicable

Completed

Conditions: Coronary Heart Disease

Interventions: Other: SPECT
Other: 3T CMR
Other: X-Ray coronary angiography
Other: CT calcium score
Other: CT coronary angiography

First Posted Date: 2012-08-14

Last Posted Date: 2018-11-23

Lead Sponsor: University of Leeds

Target Recruit Count: 1202

Registration Number: NCT01664858

Locations: 🇬🇧
Oxford University Hospitals NHS Trust, Oxford, United Kingdom
🇬🇧
Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, United Kingdom
🇬🇧
Glenfield Hospital, Leicester, Leicestershire, United Kingdom

and more 3 locations

Pacemaker Upgrade to Cardiac Resynchronisation Therapy in Patients With Left Ventricular Dysfunction Dependant Upon Right Ventricular Pacing

Not Applicable

Completed

Conditions: Left Ventricular Function Systolic Dysfunction

Interventions: Procedure: Cardiac resynchronisation therapy

First Posted Date: 2012-07-30

Last Posted Date: 2015-12-03

Lead Sponsor: University of Leeds

Target Recruit Count: 50

Registration Number: NCT01652248

Locations: 🇬🇧
Leeds General Infirmary, Leeds, United Kingdom

Preliminary Clinical Study of Ultrasound to Measure Enamel Thickness

Phase 1

Completed

Conditions: Tooth Erosion

Interventions: Other: Ultrasound transducer

First Posted Date: 2012-06-19

Last Posted Date: 2013-03-19

Lead Sponsor: University of Leeds

Target Recruit Count: 30

Registration Number: NCT01622920

Locations: 🇬🇧
University of Leeds, Leeds Dental Institute (DenTCRU), Leeds, West Yorkshire, United Kingdom

VitamIN D Treating patIents With Chronic heArT failurE

Phase 2

Completed

Conditions: Chronic Heart Failure

Interventions: Dietary Supplement: Vitamin D

First Posted Date: 2012-06-14

Last Posted Date: 2016-10-26

Lead Sponsor: University of Leeds

Target Recruit Count: 253

Registration Number: NCT01619891

Locations: 🇬🇧
Leeds General Infirmary, Leeds, United Kingdom

Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients

Phase 3

Conditions: Multiple Myeloma

Interventions: Drug: Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen
Drug: Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen
Drug: Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen
Drug: Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen
Drug: Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen
Drug: Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen
Drug: Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance
Drug: Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance
Drug: High dose melphalan therapy and autologous stem cell transplant (intensive pathway only)

First Posted Date: 2012-03-15

Last Posted Date: 2018-06-11

Lead Sponsor: University of Leeds

Target Recruit Count: 4420

Registration Number: NCT01554852

Locations: 🇬🇧
112 sites UK wide, United Kingdom, United Kingdom

The Leeds Women's Wellbeing (LWW) Study

Not Applicable

Completed

Conditions: Weight Loss

Interventions: Other: Healthy eating diet (Diet A) or healthy eating diet combined with advice to increase fibre intake (Diet B) to at least 25g/day

First Posted Date: 2012-02-27

Last Posted Date: 2014-05-22

Lead Sponsor: University of Leeds

Target Recruit Count: 80

Registration Number: NCT01539369

Locations: 🇬🇧
Institute of Psychological Sciences, Leeds, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy